Evidence map›Paper›PMID 34444822›Full record

ArticleNutrients2021

The Association of Nighttime Fasting Duration and Prostate Cancer Risk: Results from the Multicase-Control (MCC) Study in Spain.

Anna Palomar-Cros, Ana Espinosa, Kurt Straif, Beatriz Pérez-Gómez, Kyriaki Papantoniou, Inés Gómez-Acebo, Ana Molina-Barceló, Rocío Olmedo-Requena, Juan Alguacil, Guillermo Fernández-Tardón and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07262593 (Family-Based Meal Timing for Cancer Prevention Among Native Hawaiian and Other Pacific Islanders), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07262593 naterminatednot on this mapstarted 2024, after this paper: background citation

Family-Based Meal Timing for Cancer Prevention Among Native Hawaiian and Other Pacific Islanders: FAMTIME

TypeinterventionalSponsorUniversity of UtahRan2024 to 2024Enrolled2ConditionsCancer PreventionArmsTime Restricted Eating (TRE), Medically Tailored Meals (MTM)
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 2 countries.

Anna Palomar-CrosBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.ORCID 0000-0001-8151-9290
Ana EspinosaBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
Kurt StraifBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
Beatriz Pérez-GómezConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4299-8214
Kyriaki PapantoniouDepartment of Epidemiology, Centre of Public Health, Medical University of Vienna, 1090 Vienna, Austria.
Inés Gómez-AceboConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Ana Molina-BarcelóCáncer y Salud Pública, FISABIO, 46020 Valencia, Spain.
Rocío Olmedo-RequenaConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-0054-6700
Juan AlguacilConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Guillermo Fernández-TardónConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Delphine CasabonneConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Nuria AragonésConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Gemma Castaño-VinyalsBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.ORCID 0000-0003-4468-1816
Marina PollánConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, 28029 Madrid, Spain.
Dora RomagueraBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
Manolis KogevinasBarcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
Instituto de Salud Carlos III · ESUniversitat Pompeu Fabra · ESBarcelona Institute for Global Health · ESCentro de Investigación Biomédica en Red · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESMedical University of Vienna · ATUniversidad de Cantabria · ESUniversidad de Granada · ESUniversidad de Oviedo · ES

Funding

Instituto de Salud Carlos III FIS PI11/01889
6 · The paper itself

Abstract

Nighttime fasting has been inconclusively associated with a reduced risk of cancer. The purpose of this study was to investigate this association in relation to prostate cancer risk. We examined data from 607 prostate cancer cases and 848 population controls who had never worked in night shift work from the Spanish multicase-control (MCC) study, 2008-2013. Through an interview, we collected circadian information on meal timing at mid-age. We estimated odds ratios (OR) and 95% confidence intervals (CI) with unconditional logistic regression. After controlling for time of breakfast, fasting for more than 11 h overnight (the median duration among controls) was associated with a reduced risk of prostate cancer compared to those fasting for 11 h or less (OR = 0.77, 95% 0.54-1.07). Combining a long nighttime fasting and an early breakfast was associated with a lower risk of prostate cancer compared to a short nighttime fasting and a late breakfast (OR = 0.54, 95% CI 0.27-1.04). This study suggests that a prolonged nighttime fasting duration and an early breakfast may be associated with a lower risk of prostate cancer. Findings should be interpreted cautiously and add to growing evidence on the importance of chrononutrition in relation to cancer risk.

Indexed as

FastingShift Work ScheduleAdultAgedAged, 80 and overBreakfastCase-Control StudiesCircadian RhythmFeeding BehaviorHumansLogistic ModelsMaleMiddle AgedOdds RatioProstatic NeoplasmsRisk Factorsbreakfastchrononutritioncircadian rhythmsearly time-restricted feedingprolonged nighttime fastingprostate cancer

Identifiers

PMID34444822
PMCPMC8399976
OpenAlexW3190810203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.